Effect of low‐level laser therapy on chemoradiotherapy‐induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients
- 30 March 2015
- journal article
- research article
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 47 (4), 296-305
- https://doi.org/10.1002/lsm.22349
Abstract
Background and Objective Oral mucositis (OM) is considered a painful and debilitating side effect in patients receiving head and neck cancer treatment. Low‐level laser therapy (LLLT) proved to be effective to prevent and treat chemoradiotherapy‐induced OM. The aim of this study was to evaluate the effect of LLLT in the severity of OM in patients with head and neck cancer and on the release of salivary inflammatory mediators. Clinical (score of OM severity) and biochemical parameters (concentration of inflammatory mediators, growth factors, and enzymes in saliva) were used. Materials and Methods Thirty patients were randomized into two groups: control and laser. LLLT was performed three times a week in the laser group, while control group received sham irradiation. OM severity was assessed according to the World Health Organization (WHO) and National Cancer Institute (NCI) scales. Pro‐inflammatory and anti‐inflammatory cytokines (TNF‐α, IL‐6, IL‐1β, IL‐10, TGF‐β), growth factors (EGF, FGF, VEGF), and metalloproteinases (MMP2/TIMP2, MMP9/TIMP2) concentrations were assessed using ELISA test. Saliva samples were collected on admission, and at the 7th, 21st, and 35th sessions of radiotherapy. Results The laser group showed a reduction in the severity of OM, which coursed with significantly diminished salivary concentration of EGF and VEGF in the 7th radiotherapy session and of IL‐6 and FGF in the 35th. There was a trend for reduced levels of IL‐1β, TNF‐α, IL‐10, TGF‐β, MMP2/TIMP2, MMP9/TIMP2 in the laser group compared to the control, however, no statistically significant differences were found. Conclusions These findings demonstrated that LLLT was effective in reducing the severity of chemoradiotherapy‐induced OM and was associated with the reduction of inflammation and repair. Lasers Surg. Med. 47:296–305, 2015.Keywords
This publication has 47 references indexed in Scilit:
- Systematic review of miscellaneous agents for the management of oral mucositis in cancer patientsSupportive Care in Cancer, 2013
- Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti ratExperimental Biology and Medicine, 2010
- Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositisRadiation Oncology, 2010
- Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?Cancer Chemotherapy and Pharmacology, 2009
- Patient‐reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapyCancer, 2008
- Radiation Treatment Breaks and Ulcerative Mucositis in Head and Neck CancerThe Oncologist, 2008
- The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugsCancer Treatment Reviews, 2007
- Perspectives on cancer therapy-induced mucosal injuryCancer, 2004
- The pathobiology of mucositisNature Reviews Cancer, 2004
- Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in MiceScience, 2001